Showing results (101-110 of 123) with videos related to
Sort By:
Pageof 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2017
HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal AdenocarcinomaSunil R Hingorani, Lei Zheng, Andrea J Bullock, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2020
A Randomized Phase II Preoperative Study of Autophagy Inhibition with High-Dose Hydroxychloroquine and Gemcitabine/Nab-Paclitaxel in Pancreatic Cancer PatientsHerbert J Zeh, Nathan Bahary, Brian A Boone, et al.The Oncologist|August 27, 2024
Relacorilant plus nab-paclitaxel for the treatment of metastatic pancreatic ductal adenocarcinoma: results from the open-label RELIANT studyErkut H Borazanci, Nathan Bahary, Vincent Chung, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2024
Devimistat (CPI-613) With Modified Fluorouarcil, Oxaliplatin, Irinotecan, and Leucovorin (FFX) Versus FFX for Patients With Metastatic Adenocarcinoma of the Pancreas: The Phase III AVENGER 500 StudyPhilip A Philip, Vaibhav Sahai, Nathan Bahary, et al.Oncotarget|February 11, 2017
Combination epigenetic therapy in metastatic colorectal cancer (mCRC) with subcutaneous 5-azacitidine and entinostat: a phase 2 consortium/stand up 2 cancer studyNilofer S Azad, Anthony El-Khoueiry, Jun Yin, et al.The New England Journal of Medicine|October 18, 2013
Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabineDaniel D Von Hoff, Thomas Ervin, Francis P Arena, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2015
Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic CancerDaniel V T Catenacci, Melissa R Junttila, Theodore Karrison, et al.Cancer|August 2, 2018
Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinomaRandall Brand, Erkut Borazanci, Virginia Speare, et al.Gastroenterology|February 28, 2018
Loss of Chromatin-Remodeling Proteins and/or CDKN2A Associates With Metastasis of Pancreatic Neuroendocrine Tumors and Reduced Patient Survival TimesSomak Roy, William A LaFramboise, Ta-Chiang Liu, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 8, 2020
KRAS amplification in metastatic colon cancer is associated with a history of inflammatory bowel disease and may confer resistance to anti-EGFR therapyLaura A Favazza, Christine M Parseghian, Cihan Kaya, et al.Pageof 13